Study protocol of a multicentre randomised controlled trial of self-help cognitive behaviour therapy for working women with menopausal symptoms (MENOS@Work) by Hunter, Myra S. et al.
RUNNING HEAD: MENOS@WORK 
 
1 
 
Title: Study protocol of a multicentre randomised controlled trial of self-help cognitive behaviour 
therapy for working women with menopausal symptoms (MENOS@Work) 
Myra S Hunter1, Claire Hardy1*, Sam Norton1, Amanda Griffiths2 
Department of Psychology (at Guy’s), 
1. Institute of Psychiatry, Psychology and Neuroscience, 
Kings College London, 
5th Floor Bermondsey Wing, 
Guy’s Campus, 
London SE1 9RT, UK. 
 
2. Division of Psychiatry & Applied Psychology,  
(School of Medicine), University of Nottingham, 
Institute of Mental Health,  
University of Nottingham Innovation Park,  
Triumph Road,  
Nottingham NG7 2TU, UK. 
 
 *Correspondence: claire.hardy@kcl.ac.uk 
Institute of Psychiatry, Psychology and Neuroscience, 
Kings College London, 
5th Floor Bermondsey Wing, 
Guy’s Campus, 
London SE1 9RT, UK. 
 
RUNNING HEAD: MENOS@WORK 
 
2 
 
Abstract   
Background: Hot flushes and night sweats (HFNS) - the main symptoms of the menopause 
transition - can impact on quality of life and are particularly difficult to manage at work. A 
cognitive behaviour therapy (CBT) intervention has been developed specifically for HFNS that is 
theoretically based and shown to reduce significantly the impact of HFNS in several randomised 
controlled trials (RCTs). Self-help CBT has been found to be as effective as group CBT for these 
symptoms, but these interventions are not widely available in the workplace. This paper describes 
the protocol of an RCT aiming to assess the efficacy of CBT for menopausal symptoms 
implemented in the workplace, with a nested qualitative study to examine acceptability and 
feasibility. 
Methods/Design: One hundred menopausal working women, aged 45-60 years, experiencing 
bothersome HFNS for two months will be recruited from several (2-10) large organisations into a 
multicentre randomised controlled trial. Women will be randomly assigned to either treatment (self-
help CBT intervention lasting 4 weeks) or to a no treatment-wait control condition (NTWC), 
following a screening interview, consent, and completion of a baseline questionnaire. All 
participants will complete follow-up questionnaires at 6 weeks and 20 weeks post-randomisation. 
The primary outcome is problem rating of HFNS; secondary measures include HFNS frequency, 
mood, quality of life, attitudes to menopause, HFNS beliefs and behaviours, work absence and 
presenteeism, job satisfaction, job stress, job performance, disclosure to managers and turnover 
intention. Adherence, acceptability and feasibility will be assessed at 20 weeks post-randomisation 
in questionnaires and qualitative interviews. Upon trial completion, the control group will also be 
offered the intervention.  
Discussion: This is the first randomised controlled trial of a self-management intervention tailored 
for working women who have troublesome menopausal symptoms.  
Trial registration: Clin.Gov  [left blank for review] 
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Background 
There are over 3.5 million women in employment aged between 50 and 65 in the UK [1] and, as 
menopause occurs on average between the ages of 50–51 and can last for up to ten years [2] at any 
one time, a significant proportion of mid-aged and older women workers will be experiencing 
menopausal symptoms. Hot flushes and night sweats (HFNS) are the main symptoms of the 
menopause, which for an estimated 20-25% affect quality of life (QOL) largely due to discomfort, 
embarrassment and the impact of night sweats upon sleep [3,4].  
There is a lack of awareness and communication about menopause generally in work 
settings. There is some evidence that women find that menopausal symptoms are hard to manage at 
work, and that certain work situations such as formal meetings, working with men and/or younger 
colleagues, and working in hot or poorly ventilated environments, increase the intensity of 
menopausal symptoms [5-9].  Hot flushes are often seen as embarrassing and women are concerned 
about the reactions of others [6]. Women tend to be reluctant to disclose their menopausal status, 
particularly at work, where embarrassment and fear of ridicule is common, and self-control is 
highly valued [7,8]. A recent review highlighted the potential impact of menopausal symptoms for 
working women [10]. Menopause symptoms may affect work capacity for some women, or their 
self-perceived work ability [11], particularly if depressive symptoms are also reported, but the 
evidence is mixed [12-18] and more research is needed [10].  
Griffiths et al [9] conducted a study of 896 women employed in ten UK-based organisations. 
Some women found that the menopause transition lead to difficult at work, and the more 
problematic symptoms reported by women were poor concentration, tiredness, poor memory, 
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feeling low/depressed and lowered confidence. Hot flushes were described as a major source of 
discomfort and embarrassment. The majority were unwilling to disclose menopause-related health 
issues to line managers, most of whom were men or younger than them. Areas suggested for 
organisational-level support included: (i) greater awareness among managers about menopause as a 
possible occupational health issue; (ii) flexible working hours; (iii) access to information and 
sources of support at work; and, (iv) attention to work place temperature and ventilation. This 
protocol aims to address (iii). 
Hormone therapy (HT) is an effective medical treatment for menopausal symptoms [18], but 
not all women want to take it due to contraindications and personal preference. Cognitive behaviour 
therapy (CBT) is an effective treatment for anxiety and depression [18], and a CBT intervention has 
been developed to help women to manage for HFNS [19-22]. CBT examines the relationships and 
interactions between physical symptoms, thoughts, feelings and behaviours. CBT for HFNS is 
based on a theoretical model [24] that includes the processes of symptom perception, cognitive 
appraisal and behavioural reactions, and the model has been supported in recent studies [25-27]. 
HFNS can be potentiated by stress and are exacerbated by negative beliefs and behavioural 
reactions [23]. The intervention includes psychoeducation and evidence-based CBT strategies to 
reduce stress, and to manage hot flushes, night sweats and sleep [24].  For example, women are 
asked to note down what they are thinking when they are stressed or when they are having a hot 
flush, and are then helped to generate calmer, supportive thoughts using examples. Beliefs about hot 
flushes in social contexts, such as ‘everyone is looking at me’, can increase arousal and hot flush 
intensity; similarly, sleep difficulties are often maintained by worry (e.g. “how will I get through the 
day tomorrow?”), which impacts further on daytime functioning. 
The CBT intervention for HFNS has been found to be effective in reducing the impact of 
HFNS, i.e. how problematic they are, in several clinical trials [19-22]. Recent UK guidance [18] 
recommends that doctors offer women information about CBT for menopausal symptoms, and, in a 
recent Position Statement on non-hormonal interventions for vasomotor symptoms, CBT is strongly 
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recommended by the North American Menopause Society [23]. CBT appears to work by changing 
symptom perceptions and cognitive appraisals (women’s perceptions, attitudes and beliefs about 
menopause and symptoms) and well as using helpful behavioural strategies, such as using calm 
breathing [24,26-27].  
Group and self-help CBT for HFNS have been shown to be effective in reducing the impact 
of HFNS compared to a control group [19]; the self-help booklet (containing the same information 
with a breathing/relaxation CD) was as effective as the group CBT. Self-help CBT has also been 
found to produce similar levels of improvement when delivered with miminal guidance [21]. The 
CBT interventions for HFNS are available in self-help and group formats [28,29], but are not yet 
widely accessible to women at work.  
This paper describes the protocol for a proposed investigation that aims to test whether a 
modified form of Self-help CBT is effective in meeting the needs of working women who have 
menopausal symptoms. We hypothesize that CBT will be more effective than no treatment in: (i) 
reducing the impact of HFNS (problem-rating), and (ii) improving mood and quality of life, 
attitudes, beliefs and behaviours, and experience of work (work absence, presenteeism, job 
satisfaction, job stress, job performance, and turnover intention).   
 
Methods/Design 
Pilot study to develop the intervention 
The self-help CBT intervention (SH-CBT) for HFNS will be modified and piloted. We will 
draw upon previous interviews with working menopausal women [9,30] and modify the existing 
CBT intervention [19,28] to include specific issues and examples relating to working life. A 
minimum of ten, working women will be invited to take part in interviews if they have menopausal 
symptoms, including HFNS. They will be asked about their experience of menopause at work, and 
their views on the content and particularly on the format of the intervention, e.g. booklet or on-line 
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version, and questionnaires to be used in the trial. If there is considerable variety in responses then 
more women will be interviewed in order to reach saturation, whereby similar themes are 
repeatedly mentioned. The intervention and questionnaires will then be modified accordingly and 
any necessary changes made before commencement of the main study. An advisory group will 
oversee the running of the project and include service users and stakeholders who will input to the 
design and review the study materials. 
 
Main Study 
Design  
The study uses a two parallel groups design to assess the outcomes and feasibility of implementing 
an evidence-based SH-CBT intervention, adapted to help working women to manage the impact of 
menopausal symptoms, in a multicentre randomised controlled trial (RCT). We will compare SH-
CBT with a no treatment-wait control condition (NTWC), at 6 and 20 week post-randomisation 
follow-up assessments (Fig 1).  Between-group comparisons will be made at 6 and 20 weeks to 
estimate the effects of SH-CBT versus NTWC using an intention to treat analysis.  
 
Ethical approval 
The study has been approved by [removed for review].  
 
Participants’ eligibility 
Working women, aged 45-60 years, with at least 10 problematic hot flushes per week (score >2) 
Hot Flush Rating Scale [5], for at least two months will be eligible for the study. They will have a 
good understanding of English and not currently experiencing major physical or mental health 
problems that would compromise participation.  
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Recruitment 
Mid-aged women (aged 45 to 60 years) will be contacted via the Occupational Health or Human 
Resources Departments (or appointed contact person) of several large organisations (minimum of 2 
maximum 10) using various modes of communication (e.g. email, intranet, posters etc.) and invited 
to contact the researcher if they are experiencing menopausal symptoms. Interested participants will 
be screened to ensure they meet the eligibility criteria. We aim to have equal numbers of 
participants from each organisation and it is estimated that a minimum of 100 women will 
participate.  
 
Randomisation and blinding 
Women who meet the inclusion criteria will be randomised into SH-CBT (n=50) or NTWC (n=50). 
Randomisation (using the RANDBETWEEN function in Microsoft Excel) will be in the ratio of 
1:1, stratifying on the basis of centre, and will occur after the screening and baseline assessment 
conducted. Women will be informed of their group allocation by post and/or email. Study materials, 
including post intervention questionnaires, will be sent out by the researcher. The data will be 
entered by a researcher blind to group allocation and the main statistical analyses carried out by the 
statistician who is blind to group allocation. 
 
Sample size 
With reference to results from a previous study [19], a total sample size of 80 participants, 40 per 
arm, are required to detect 2 points difference in HFNS mean score at 6 weeks using regression 
analysis controlling for baseline level of the outcome, with a 90% power at 2 tailed significance 
0.05 level, assuming equal SD (3.0) for both groups and correlation between baseline and follow up 
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measures at 0.4 for the purpose of being conservative. After taking into account 20% loss to follow 
up rate, a sample size of 100 is required.  
 
Self-help CBT intervention (SH-CBT) 
The intervention is a modified version of an existing evidence-based SH-CBT intervention [19,22]. 
It will be shortened and adapted during pilot work but it is expected that it will include a booklet 
with evidence-based information on menopause and coping strategies for work settings and a 
breathing/relaxation practice that can be downloaded or provided on a CD. The approach is psycho-
educational with an active focus upon cognitive and behavioural changes. This intervention lasts for 
4 weeks and the materials guide the individual through each chapter and exercise, including the 
homework set out for each chapter. In total, this intervention is estimated to take approximately 4 
hours a week over the 4 weeks, not in work time.  
It is anticipated that the booklet will contain the following components: 
 Information and advice about menopause and menopausal symptoms with physiological 
explanation and factors influencing their experience (cognitive behavioural model) 
 Monitoring and modifying hot flush precipitants in the work environment 
 Paced breathing, relaxation and dealing with stress  
 Exercises to challenge unhelpful thoughts and beliefs about menopause and others’ reactions  
 Encouraging helpful behavioural strategies, e.g. reducing avoidance, pacing activities 
 Information and strategies for managing night sweats and sleep  
 Information about additional resources 
 
No Treatment-Wait Control (NTWC) 
Control participants do not receive CBT treatment but have access to their GP, occupational health 
RUNNING HEAD: MENOS@WORK 
 
9 
 
and other healthcare options, as would normally be the case. They will be offered the SH-CBT 
intervention off-trial following completion of A2.  
 
 
Measures 
These have been used in previous studies by the authors and have good psychometric properties. 
The measures are completed at assessment points (baseline (A0), 6 weeks (A1) and 20 weeks (A2) 
post-randomisation), as indicated in Table 1. 
Background and demographic measures: Age, ethnicity, family and relationship status, employment 
status, type of work (i.e. shift work; manual, non-manual work, both; uniform required), work 
context and environment (i.e. working with others, Health and Safety Executive’s (HSE) 
Management Standards Indicator Tool [31]), job title, menopause status, menopausal symptoms, 
HRT use and history, treatment for HF/NS, current health conditions, and general health questions 
(i.e. to measure BMI, physical activity, alcohol and smoking consumption, and a general health 
item).  
Primary outcome:  
HFNS Problem-rating is a subscale of the Hot Flush Rating Scale [5] calculated as the mean of 
three items, each measured on a 10-point scale (low to high). Items include ‘To what extent do you 
regard your flushes/ sweats as a problem?’, ‘How distressed do you feel about your hot flushes?’ 
and ‘How much do your hot flushes interfere with your daily routine? Problem rating—i.e., the 
extent to which symptoms are bothersome and interfere with life—was chosen, before the trial 
began, as the primary outcome because problem rating, rather than frequency, is associated with 
quality of life [4], and it has been recommended as an appropriate patient reported outcome measure 
in clinical trials of HFNS treatments [32,33]. The scale has good internal consistency (Cronbach 
α=0.9) and test-retest reliability (r=0.8) [5]. Problem rating and severity tend to be associated but 
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neither are strongly associated with frequency of HFNS [25,32].  
 
Secondary outcomes: 
HFNS frequency, is measured by a subscale of the Hot Flush Rating Scale [5] providing a weekly 
average of HF and NS. The measure gives a retrospective recording of the frequency of HFNS (for 
example, “How often have you had hot flushes in the past week?”) and the average severity of the 
HFNS for the previous week (1=mild, 2=moderate, 3=severe). 
Menopause Representations Questionnaire (MRQ) [34] is designed to assess women’s attributions 
(identity) of symptoms to the menopause (20 items) and beliefs subscales (cognitive 
representations) about the menopause (17 items). The belief items are scored on 5-point scales from 
strongly agree (5) to strongly disagree (1), and mean scores are calculated for beliefs subscales. The 
identity subscale items are scored from 0 to 2 and summed. We also included two belief items from 
the Menopause Attitude Measure [9] to measure attitude to menopause at work, i.e. whether women 
feel that their job performance has been affected by menopausal symptoms, and whether they feel 
that menopause has negatively affected managers’ and colleagues’ views of competence at work. 
These are scored on 5-point scales (agree (5) to strongly disagree (1)).  
 
Hot Flush Beliefs and Behaviours are assessed using a combined scale of existing measures. The 
Hot Flush Beliefs Scale (HFBelS) [35], a 27-item scale comprising three subscales including beliefs 
about HF in a social context, beliefs about ability to cope/control HFNS, and beliefs about night 
sweats and sleep.  The Hot Flush Behaviour Scale (HFBehS) [36] comprises 11 items to assess 
behavioural reactions to HFNS, i.e. avoidance, safety behaviours and positive acceptance, using a 6-
point scale from strongly disagree (0) to strongly agree (5). Both measures have been found to 
mediate the treatment effects of CBT [26,27]. A combined Short Form Hot flush Beliefs and 
Behaviour Scale (HFBelBehScale) is used in this study, which has good reliability and similar 
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correlations with HFNS Problem rating compared with the longer questionnaires (the Short Form 
HFNS Beliefs and Behaviour Scale is included in a supplementary file with scoring information). 
 
The Women’s Health Questionnaire (WHQ) [37] a measure of physical and emotional symptoms 
designed for and standardised on women aged 45–65 years, is widely used in studies of menopausal 
women. The WHQ has 37 items with subscales that assess, for example, depressed mood, anxiety, 
memory/concentration, somatic symptoms and sleep problems. Participants rate each item on a 4-
point scale, according to the extent to which they are experiencing each item; subscale scores are 
calculated, ranging from 0–1 (higher scores indicate poorer wellbeing). The depressed mood 
subscale has concurrent validity with the GHQ and the WHQ has good internal reliability for 
subscales (Cronbach α 0.70–0.84) and test-retest reliability (0.78–0.96).  A single item measure of 
sleep quality was added from the Pittsburgh Sleep Quality Index (PSQI) [38], which is a self-rated 
questionnaire assessing sleep quality and disturbances over a 1-month time interval using a 4-point 
Likert scale (1= Very bad to 4 = Very good). 
 
The Work and Social Adjustment Scale [39] measures functional impairment at work, home, and in 
social situations. It comprises 5 self-report items using an 8-point Likert scale (0=Not at all, 
8=Severely) and provides the degree of impact of menopause symptoms on a given activity 
Responses are summed to provide a score between 0 (no impairment) to 40 (very severe 
impairment).  
 
The Stanford Presenteeism Scale [40] measures an employee’s ability to concentrate and 
accomplish work despite health problems. This measure of workplace presenteeism comprises of 6 
items that are summed to produce a total presenteeism score. Each item asks the respondent to 
indicate their work experience over the last month using a 5-point scale (1=strongly disagree, 
5=strongly agree).   
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Workplace absenteeism is measured by asking participants to provide detail of any time of they 
have taken off from work over the last 4 weeks because of the menopause (i.e. duration and spells) 
[9,40], including the duration of absence spells and leaving work early or arriving late. 
 
Menopausal symptom disclosure to managers is measured using a single dichotomous item (‘yes’ or 
‘no’) [9,30] and whether participants have told their manager about any reduced working hours (i.e. 
arriving late, leaving early) due to their menopausal symptoms (if appropriate) (‘yes’, ‘no’, 
‘sometimes’).  
 
Work turnover intentions [41] are measured with 4 items that assess how likely the individual is to 
leave their organisation. Each item contains 5 response options indicating low (1) to high (5) intent 
to remain in their organisation, which are averaged to provide an overall score. Two further items 
are used to measure the degree to which the individual has considered reducing their working hours 
or leaving the workforce altogether (response options include: ‘yes’, ‘no’, ‘sometimes’).  
 
Job satisfaction is measured using a single-item 7-point Likert scale (1=extremely dissatisfied, 
4=neither dissatisfied or satisfied, 7=extremely satisfied) [9,30] to indicate an individual’s level of 
contentment with their job. Job performance is also measured using a single item; participants are 
asked to rate their performance compared to others in a similar role or position to themselves using 
a 5-point Likert scale (1=poor, 5=excellent), and job stress [42] is measured using a single item 
asking participants to indicate on a 4-point Likert scale how stressful they find their job (1=not 
stressful, 4=extremely stressful).  
 
The use of medical resources for menopause and treatments for HFNS will also be monitored, by 
asking, whether or not (and if so how often) they had visited their GP/hospital doctor/nurse about 
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the menopause (over the past 6 months at baseline and at the final follow-up) (dichotomous 
response option ‘yes’ or ‘no’) and whether they have/are currently taking any treatment (medical or 
non-medical) for HFNS. 
 
Evaluation of the intervention: adherence, acceptability and feasibility  
Adherence to relaxation practice and homework tasks will be monitored. Those who are randomised 
to SH-CBT will be asked to complete short evaluation questions within the questionnaires (at A1 
and A2) to assess adherence to the intervention, i.e. whether (and how much of the booklet) they 
read, whether they carried out the components of the interventions (listen to breathing/relaxation; 
used cognitive and/or behavioural strategies), and provide other general feedback information about 
the intervention.  
 
 
Data analysis  
The analysis will be conducted on an intention-to-treat basis, excluding participants providing no 
post-intervention follow-up data. Descriptive statistics for variables will be presented by treatment 
arms across the follow up time points. Mixed-effects (aka multilevel) models will be performed to 
quantify the treatment effects on the primary outcome (HFNS problem rating) at the 6 and 20 week 
follow-up assessments [42]. A random-intercept will be estimated to account for the repeated 
measurement of the outcomes within participants. Predictors entered into the model will be group 
allocation, time in weeks post-intervention, and a group-by-time interaction term to allow for 
estimates of the treatment effect at each time point. Additional covariates included will be the 
baseline level of the outcome variable and centre indicator variables, as this was a stratification 
factor in the randomisation. Secondary outcomes will be analysed in the same way. Any skewed 
continuous outcome variables may be transformed for multilevel modelling.  A detailed Statistical 
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Analysis Plan setting out full details of the proposed analyses will be finalised before the trial 
database is locked for final analysis. Stata 14 will be used for data analysis. 
 
Missing values in all outcomes will be checked and reported across treatment group and following 
up time. A mixed effect logistic regression will be performed to test the association between group 
allocation and baseline variables with missing outcome observations at each follow-up assessment. 
Because mixed-effects models will be used to estimate treatment effects, individuals with at least 
one post-intervention observation of the outcome will be included in the analysis with the 
assumption that missing outcome observations are missing at random (MAR) [43]. This implies that 
treatment effects will be unbiased as long as missingness is either completely at random or 
influenced only by variables included in the model, and not unobserved variables [43]. Sensitivity 
analysis will be conducted under a number of plausible missing not at random (MNAR) scenarios to 
examine the risk of bias introduced where the MAR assumption to be violated [44].  
 
If the treatment effect on the primary outcome (HFNS problem rating) is observed to be statistically 
significant, exploratory analysis will be conducted to explore the efficacy mechanism in relation to 
several putative mediators (such as HFNS beliefs, mood, HFNS frequency) using mediation 
analysis performed by the product-of coefficients approach [45]. If there is not effect on the primary 
outcome and the estimated effect size is less than .4, explanatory analysis will be conducted in order 
to determine whether poor adherence to the intervention or centre level variation were potentially 
related to the null finding. 
 
Nested qualitative study 
After the final assessment questionnaire is completed, all women in the intervention arm will be 
invited to take part in a 20-30 minute semi-structured interview to explore their perceptions of the 
feasibility, acceptability, and their experience of having the intervention. This will include their 
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perceived impact on themselves, their quality of life at work and in general their feedback on the 
intervention and its delivery. The interviews will be carried out by a research psychologist 
(telephone or face to face at the university or agreed location) and audio recorded with consent. The 
interviews will be analysed using framework analysis [46]. Fifty per cent (or 25) will be randomly 
selected before being coded and analysed by the research psychologist; 50% will be coded in 
parallel by an independent researcher to ensure reliability. Qualitative responses from the evaluation 
questionnaires will also be coded by the researcher on the project and analysed in the same way. 
Content categories will be independent checked by an additional independent researcher. 
 
Discussion 
This study will investigate the feasibility and outcome of offering a brief self-help intervention to 
help women to manage menopausal symptoms at work. To our knowledge this is the first study to 
do so and if effective the intervention could have benefits to working women, and possibly also to 
their employers. Moreover, because the majority of mid-aged women in the UK are working and 
are likely to continue to do so for 10-15 years after the menopause [1], the outcomes of the study 
could have far reaching impacts through increased availability of CBT for menopausal symptoms 
[47]. If the intervention is feasible and successful, we plan to offer it to other organizations. 
 No negative impact on the study participants is expected. Some women consider the 
menopause a taboo subject and may be embarrassed about the topic of the questionnaires and some 
content within the SH-CBT intervention (menopause, hot flushes, night sweats, etc). However, we 
plan to ensure that all potential participants are fully informed about study materials prior to 
obtaining consent and are given the opportunity to withdraw from the study, should they feel too 
uncomfortable.  As women will also be randomised into two groups, one active treatment group and 
one no-treatment group, some participants may be disappointed that they are not receiving a 
potentially helpful treatment immediately. However, we offer all no-treatment participants the 
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intervention at the end of the trial and ensure that are fully aware of the randomisation procedure 
prior to obtaining informed consent. 
 The results of the study will be disseminated by publication of journal articles and 
conference attendance. We aim to reach a variety of relevant groups, such as occupational health 
professionals, human resource managers, employers and managers, trade unions, health and 
occupational psychologists, menopause researchers, clinicians and organisational stake holders (e.g. 
at British Menopause Society Conference, International Menopause Society Congress, Society of 
Occupational Medicine Continued Professional Development events and annual scientific meetings, 
Trade Union events for health and safety representatives, Chartered Institute of Personnel and 
Development annual conference, Health and Wellbeing at Work conference). In addition to 
academic papers, outlets will be sought in professional and practitioner magazines. 
 Future research might include development and evaluation of on-line versions of the 
intervention and translations into additional languages. We are also planning to develop and 
evaluate a brief intervention for managers and employers to increase knowledge and awareness of 
the menopause and the needs of menopausal women. 
 
Supplementary file (attached) 
Abbreviations 
CBT (cognitive behaviour therapy);  SH-CBT (self-help cognitive behaviour therapy); HFNS  (hot 
flushes and night sweats); NTWC (No Treatment-Wait Control); Quality of life (QOL); WHQ 
(Women’s Health Questionnaire); WASAS (Work and Social Adjustment scale); MRQ (Menopause 
Representations Scale); HFBelS (Hot Flush Beliefs Scale); HFBeS (Hot Flush Behaviour Scale); 
HFBelBehScale (Hot Flush Beliefs and Behaviour Scale);  MAR (missing at random).  
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